GLP1R and medullary thyroid gland carcinoma: Several studies have found that GLP-1 receptor agonists may cause thyroid C-cell adenomas and C-cell carcinomas in rodents (26, 27), and thus GLP-1 receptor agonists are contraindicated in those with a history of medullary thyroid cancer.